AI in Cancer Care | Alyssa Schatz, NCCN Policy & Advocacy

59 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Live from the NCCN Policy Summit at the National Press Club in Washington, DC — I sit down with Alyssa Schatz, Vice President of Policy and Advocacy at the National Comprehensive Cancer Network (NCCN).

In this conversation, Alyssa explains:

Why NCCN brings together diverse voices at its AI in cancer care policy summits

How stakeholders — from pathologists, radiologists, and oncologists to pharma, payers, policymakers, and patient advocates — are shaping the future of AI in oncology

The importance of guardrails, trust, and responsible implementation of artificial intelligence in healthcare

How NCCN translates these discussions into policy reports and advocacy that influence cancer care in the U.S. and worldwide

If you’re interested in cancer policy, digital pathology, or the evolving role of AI in oncology, this is a must-watch recap from one of the most influential voices in the field.

???? Subscribe for more updates from the NCCN Policy Summit and beyond: [https://www.youtube.com/@aleksandrazurawpathology?sub_confirmation=1]

Key Highlights

Alyssa Schatz introduces herself and the role of NCCN in convening diverse stakeholders
Overview of panel discussions on AI in cancer care
Audience engagement: healthcare professionals, patient advocates, pharma, researchers, payers
Top questions explored: challenges, policy solutions, and organizational support for AI integration
The role of trust and guardrails in making AI safe, effective, and ethical
Next steps: NCCN’s upcoming policy report and its global impact
Categoria
Oncology
Commenta per primo questo video.

Prossimo